BHVN Insider Trading

Biohaven Ltd. (BHVN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $1.65B, listed on NYSE, employing roughly 274 people, carrying a beta of 3.20 to the broader market. Biohaven Ltd. Led by Vladimir Coric, public since 2022-09-23.

In the last 12 months, Biohaven Ltd. insiders made 6 buy transactions and 0 sale transactions.

DateNameTypeSharesPriceValue
Sep 17, 2026Gentile KimberlyA-Award1,000$12.34$12.3K
Aug 14, 2026Yetimoglu John0$0.00$0
Jul 17, 2026Volles Warren Karl0$0.00$0
Jul 17, 2026Volles Warren Karl95,250$41.93$4.0M
Jul 17, 2026Volles Warren Karl83,000$38.64$3.2M
Jul 17, 2026Volles Warren Karl175,000$11.52$2.0M
Jul 17, 2026Volles Warren Karl14,000$0.00$0
Jul 17, 2026Volles Warren Karl300,000$7.00$2.1M
Jul 17, 2026Volles Warren Karl78,750$29.49$2.3M
Apr 30, 2026Mehta KishanA-Award68,693$9.61$660.1K

BHVN Insider Activity by Quarter

Reported Form 4 and Form 5 lines under BHVN's own SEC company ID, by transaction date, back to Q4 2024. Purchases and sales are code P / S (open market or private) in the company's shares; other lines are purchases and sales of other securities (options, warrants, preferred), awards, exercises, tax withholding, gifts and other acquisitions and dispositions. Later filings and amendments can change the current quarter. Earlier quarters are not shown: the filings read reach back to Jan 12, 2022, and a quarter counts only when every filing for it was read. 195 lines filed under another SEC company ID are not counted.

QuarterPurchasesBoughtSalesSoldOther Lines
Q4 2026 (so far)0N/A0N/A0
Q3 20260N/A0N/A1
Q2 20260N/A0N/A7
Q1 20260N/A0N/A22
Q4 20255$33.1M0N/A0
Q3 20250N/A0N/A0
Q2 20250N/A0N/A7
Q1 20255$1.9M0N/A25
Q4 20243$3.0M0N/A0

Filings Under Another SEC Company ID

195 filing lines on file were filed under an SEC company ID (CIK) other than BHVN's (1935979). Such a filing can be a predecessor company's (one that reorganized, redomiciled or converted files under a new CIK), a former holder of the BHVN ticker's, or another company's that BHVN or its insiders report holding; the CIK alone does not say which. They are not counted in the figures above.

CIKLinesDatesSecurities
1689813195Jun 11, 2020 to Oct 5, 2022Common Shares, Stock Options (Right to Buy), Stock Options (Right to buy)

BHVN Institutional Ownership (13F)

As of Jun 30, 2026 (Q2 2026), 295 institutions reported holding 141,118,351 BHVN shares, valued at $2.10B as reported, 89.8% of its market cap (market cap of Jun 26, 2026). 1 of them reported some or all of their shares on another basis (before a reverse split, or as ADRs): they are in the institutions and the value, those shares not in the shares. That is +17 institutions from the quarter before. Among managers whose reports for both quarters are comparable, 48 opened a position, 29 closed one, 109 added and 87 trimmed.

Top Holders, Q2 2026

ManagerSharesValueChange
BlackRock, Inc.13,210,585$196.6M+1,988,178
MONTANOVA CAPITAL, LLC10,286,937$153.1MUnchanged
STIFEL FINANCIAL CORP9,941,165$147.9M+280
Jupiter Topco LLC8,584,675$127.9MNo comparable report
Woodline Partners LP7,660,280$114.0M+7,359,891
STATE STREET CORP6,947,034$103.4M+328,231
INFINITUM ASSET MANAGEMENT, LLC6,250,000$93.0MUnchanged
D. E. Shaw & Co., Inc.4,190,195$62.4M+1,343,002
AQR CAPITAL MANAGEMENT LLC4,150,616$61.8M+2,175,100
GEODE CAPITAL MANAGEMENT, LLC3,323,190$49.5M+555,427

By Quarter

QuarterInstitutionsSharesValue
Q2 2026*295141,118,351$2.10B
Q1 2026278146,008,026$1.24B
Q4 2025275123,897,390$1.40B
Q3 202526686,583,703$1.30B
Q2 202525188,039,073$1.24B
Q1 202526491,100,044$2.24B
Q4 202425693,058,450$3.51B
Q3 202425386,937,239$4.34B
Q2 202422684,885,884$2.95B

* Q2 2026: 1 with shares on another basis (not in the shares).

From the SEC's Form 13F data sets: investment managers with $100 million or more in Section 13(f) securities report their holdings each quarter, up to 45 days after it ends; a restated filing replaces the original, and values are as the managers reported them (a position whose price runs about 1,000 times below other managers', from a manager whose positions mostly do, is read as reported in thousands of dollars). The same shares can be reported by more than one manager, so totals can count some twice.

ETFs Holding BHVN

FundWeight of BHVNShares (as reported)Value (as reported)Source updated
XBI State Street SPDR S&P Biotech ETF0.45%3,749,117$45.2MOct 8, 2026
IWM iShares Russell 2000 ETF0.05%3,504,211$41.6MOct 8, 2026
IWO iShares Russell 2000 Growth ETF0.11%1,248,218$14.8MOct 8, 2026
IBB iShares Biotechnology ETF0.11%972,192$11.5MOct 8, 2026
SCHA Schwab U.S. Small-Cap ETF0.04%653,820$7.8MOct 8, 2026
FESM Fidelity Enhanced Small Cap ETF0.07%411,167$4.9MOct 8, 2026
PRFZ Invesco RAFI US 1500 Small-Mid ETF0.11%254,867$3.0MOct 8, 2026
LABU Direxion Daily S&P Biotech Bull 3X Shares0.11%172,954$2.1MOct 8, 2026
ITOT iShares Core S&P Total U.S. Stock Market ETF0.00%169,941$2.0MOct 8, 2026
ESML iShares ESG Aware MSCI USA Small-Cap ETF0.07%160,263$1.9MOct 8, 2026
NUSC Nuveen ESG Small-Cap ETF0.12%121,322$1.4MOct 8, 2026
SCHB Schwab U.S. Broad Market ETF0.00%83,605$1.0MOct 8, 2026
RSSL Global X - Russell 2000 ETF0.05%63,224$763.7KOct 7, 2026
FHLC Fidelity MSCI Health Care Index ETF0.02%62,663$744.4KOct 8, 2026
BBSC JPMorgan BetaBuilders U.S. Small Cap Equity ETF0.07%38,964$501.5KOct 5, 2026

From each fund's latest holdings file on record that shows BHVN's listed security itself. A file counts when its line count is consistent with the fund's reported holdings count (at most twice it plus 10, or at most 1,000 lines for a reported count of exactly 10, which the data source gives many funds as a cap), read with that file or inherited from the fund's last classified file (within 20% of its line count, read within 60 days). Funds whose line for the company could not be confirmed as BHVN's listed security, or that hold it through underlying funds (look-through), are not listed. Only long positions count: a fund is left out when any of its lines for BHVN reports a negative weight, share count or value, or none of them above zero (a short position, or figures that disagree). Shares, value and weight are as reported in each fund's file, dated by the data source's last update of that file (not the date of the positions); the weight is BHVN's share of that fund.

How to Read BHVN Insider Activity

Net insider sentiment is bullish over the trailing twelve months: 6 buy transactions versus 0 sales. Cluster buying by officers or directors is one of the cleaner insider signals because purchases require personal capital deployment and carry direct SEC scrutiny for material non-public information violations. The transaction table above includes the filer's reporting name, transaction type, share count, per-share price, and total dollar value where computable. For options traders, insider activity is one input to event-driven sizing alongside earnings calendar, analyst-rating cluster moves, and the implied-vol surface. Form 4 filings (the dominant Section 16 reporting form) must be submitted within two business days of the transaction; clusters of buys across multiple insiders within a short window are the strongest informational pattern. SEC EDGAR carries the underlying source filings for verification and additional historical depth.

Learn how insider trading is reported and how to read the data →

Frequently asked BHVN insider trading questions

How active are BHVN insiders right now?
Over the trailing twelve months, Biohaven Ltd. (BHVN) insiders made 6 buy transactions and 0 sale transactions. Net insider sentiment over the trailing twelve months tilts to the buy side (6 buys vs 0 sales). The transaction list above shows the most recent filings; each entry includes the insider's name, transaction type, share count, and per-share price.
What counts as an insider transaction?
Section 16 of the Securities Exchange Act requires officers, directors, and 10% beneficial-owner shareholders to disclose changes in their holdings via Form 3 (initial statement), Form 4 (subsequent transactions, filed within two business days), and Form 5 (annual catch-up). Insider transactions cover open-market purchases and sales, exercise of stock options, gifts, and grants. The "transaction type" field on each row distinguishes these subcategories.
Are BHVN insider buys a bullish signal?
Insider purchases (Type P, made on the open market or privately; the code covers both) carry more informational weight than insider sales: an insider must commit personal capital, and the SEC scrutinizes purchases under Rule 10b5-1 for material non-public information. Sales, by contrast, are often driven by liquidity, tax planning, or pre-scheduled 10b5-1 trading plans rather than negative information. Cluster buying (multiple insiders buying within a short window) is a stronger signal than isolated buys.
How do BHVN insider transactions affect options pricing?
Insider transaction data does not directly drive implied volatility, but Form 4 disclosures can move single-name IV if the size or timing is unusual (e.g. a large CEO buy ahead of an earnings window). Options markets price the marginal informational content; routine transactions under pre-scheduled plans are typically ignored. For event-driven options sizing, pair the insider transaction history with the upcoming earnings calendar.